Not applicableWithdrawnNCT01159236What this trial is testingMolecular Triaging of Newly Diagnosed Breast CancerWho this might be right forBreast Cancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00856492What this trial is testingS0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast CancerWho this might be right forBreast Cancer SWOG Cancer Research Network 215
Not applicableWithdrawnNCT02102438What this trial is testingChemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast CancerWho this might be right forBreast CancerHER-2 Positive Breast Cancer Instituto do Cancer do Estado de São Paulo
Testing effectiveness (Phase 2)Active Not RecruitingNCT05296746What this trial is testingNeoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast CancerWho this might be right forBreast Cancer Stage II SOLTI Breast Cancer Research Group 1,100
Testing effectiveness (Phase 2)Looking for participantsNCT06967103What this trial is testingQL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast CancerWho this might be right forBreast CancerHR+/HER2- Breast Cancer Henan Cancer Hospital 238
Not applicableLooking for participantsNCT06744465What this trial is testingNearWave Optical Molecular MonitoringWho this might be right forBreast CancerHER2-positive Breast CancerTNBC - Triple-Negative Breast Cancer+2 more Indiana University 15
Testing effectiveness (Phase 2)Looking for participantsNCT06178159What this trial is testingDV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast CancerWho this might be right forBreast Cancer RemeGen Co., Ltd. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07246317What this trial is testingEvaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast CancerWho this might be right forBreast Cancer Tianjin Medical University Cancer Institute and Hospital 188
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06973525What this trial is testingThis Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy.Who this might be right forHER2-positive Breast Cancer Hebei Medical University Fourth Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07748260What this trial is testingDe-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early BreastWho this might be right forHER2-positive Breast Cancer Guangdong Provincial People's Hospital 592
Not applicableUnknownNCT06479460What this trial is testingClinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer PatientsWho this might be right forBreast CancerNeoadjuvantHER2-positive Breast Cancer+1 more The First Affiliated Hospital with Nanjing Medical University 50
Large-scale testing (Phase 3)Looking for participantsNCT06891833What this trial is testingBL-M07D1 With or Without Pertuzumab Versus Docetaxel + Carboplatin + Trastuzumab + Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast CancerWho this might be right forHER2-positive Breast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 985
Early research (Phase 1)Looking for participantsNCT05989347What this trial is testingStudy to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant TherapyWho this might be right forBreast CancerHyperinsulinismHER2-negative Breast Cancer Yale University 20
Not applicableLooking for participantsNCT04281641What this trial is testingMarkers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast CancerWho this might be right forHER2-positive Breast Cancer Fudan University 94
Post-approval studies (Phase 4)Not Yet RecruitingNCT06613373What this trial is testingAn Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast CancerWho this might be right forBreast Cancer Jiangsu Famous Medical Technology Co., Ltd. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07565324What this trial is testingPhase II Study of Ultrasound and ctDNA Guided Neoadjuvant Systemic Therapy for Patients With HER2-positive Early Breast Cancer (UC HER Trial)Who this might be right forHER-2 Positive Breast Cancer National Taiwan University Hospital 54
Testing effectiveness (Phase 2)UnknownNCT00491816What this trial is testingErlotinib Plus Chemotherapy for Treatment of Triple Negative Breast CancerWho this might be right forBreast Cancer University of Kansas Medical Center 32
Not applicableStudy completedNCT03981705What this trial is testingAssessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast CancerWho this might be right forTN ER-/PR-/HER2- Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer+1 more Masonic Cancer Center, University of Minnesota 8
Testing effectiveness (Phase 2)UnknownNCT04717531What this trial is testingPyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast CancerWho this might be right forBreast Cancer The First Affiliated Hospital with Nanjing Medical University 60
Not applicableUnknownNCT05561686What this trial is testingReal-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast CancerWho this might be right forHER2-positive Breast Cancer Hunan Cancer Hospital 100